Olin Hyde Launches Englue, Inc. to Cure Medical Research

Applying ai-one’s technology to the world’s information problems is an exciting part of our job.  There isn’t a week that goes by without a customer in a new domain experiencing the pain caused by big data and lousy language tools.  While we love the breadth of this challenge, each of us has our favorite problem we would love to focus on to change the world.

For Olin Hyde, our former VP Business Development, it has always been medicine.  He has the intellectual curiosity and bandwidth to understand medicine and its intersection with information technology, and has lobbied for us to focus solely on this market.  Within our partner model, this passion was focused on trying to find and develop an OEM Partner to work with.  Since he couldn’t find one, on August 1st he did what any good entrepreneur would do when he sees a big opportunity, he founded his own company.  His mission for Englue Inc. is to become the ai-one OEM Partner that will change medicine’s approach to research.

Are we bummed he left?  Sure we are.  But he hasn’t left the family and as a partner applying our unique form of biologically inspired intelligence to medical research, we are confident Olin will create a big success story for both of us. This form of intelligence will spawn a huge number of new applications over the next decade.  Olin has been part of a team that has ten years’ experience applying this new form of computing to real application problems giving him a huge competitive advantage.

Building off our new Nathan API and the platform and tools ai-one calls the Analyst Toolbox, Englue will be launching a series of products for the medical researcher that will enable them to fully leverage the vast amount of publications and clinical studies from around the globe.  We look forward to working with Olin and the Englue team and wish him the best of success.

Comments are closed.